FDA warns of potential hepatotoxicity with Voltaren Gel - MPR
Links shared publicly online about this topic.
- 1,548total visits
FDA warns of potential hepatotoxicity with Voltaren Gel - MPR
empr.com —
Endo, Novartis, and the FDA have notified healthcare professionals that the Voltaren Gel (diclofenac sodium gel) Prescribing Information has been updated to include new warnings and precautions about the potential for elevation in liver function tests during treatment with all products containing diclofenac sodium.
View full resource at empr.com
Tags: Mineral, Sodium, Healthcare, FDA, NSAIDs, Voltaren, Cataflam, Novartis
Most Recently Shared on December 7, 2009 at 4:43 pm By:
MPR News: FDA warns of potential hepatotoxicity with Voltaren Gel: Endo, Novartis, and the FDA have notified health... http://bit.ly/5jqplA
Voltaren Gel Side Effects May Result in Liver Problems: FDA - AboutLawsuits.com
aboutlawsuits.com — “The FDA has announced that it is requiring new warnings about potential side effects of Voltaren gel, an arthritis topical treatment that may cause liver” View full resource at aboutlawsuits.com
Most Recently Shared on December 16, 2009 at 7:45 pm By:
Voltaren Gel Side Effects May Result in Liver Problems: FDA … http://short.to/10sif
Advertisement
